Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2023-01-06 00:00:00 ET · period of report 2023-01-04 · accession 0001453687-23-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-06 | 2023-01-04+ | RNAC | Johnston Lloyd P. | Chief Ops Off | S - Sale | $1.13 | -9,784 | 268.9K | -4% | -$11.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-04 | S | D | 6,381 | $1.13 | 268,918 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-05 | S | D | 20 | $1.11 | 265,515 | D | — | — | |
| 3 | Common | Common Stock | 2023-01-05 | S | D | 3,372 | $1.13 | 265,535 | D | — | — | |
| 4 | Common | Common Stock | 2023-01-04 | S | D | 11 | $1.14 | 268,907 | D | — | — |